This study aims to assess the clinical benefit of local ablative therapy (LAT) following initial standard fist-line systemic treatment, compared to continued standard first-line systemic treatment in patients with unresectable oligometastatic CRC.
TROG Cancer Research
Dr Julie Chu
The RAVES trial treating prostate cancer Participating in a
Ductal carcinoma in situ (DCIS) of the breast is
For over 30 years, TROG Cancer Research has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.
Keep up to date with TROG news, subscribe to our community newsletter.